As the CD8+ T cells appear crucial for NLGP-mediated tumor restriction [16] and a post-surgical surge of this particular type of T cells is observed in NLGP-treated mice, it was further ascertained how CD8+ T cell depletion affects recurrence in surgically tumor-removed NLGP-treated mice. Here, CD8A is linked to neoplasm.